Nutritional supplements in pregnancy: Commercial push or evidence based?

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 6, 2006, Pages 642-647

  Glenville, Marilyn ^a  

^a NONE   (United Kingdom)

Author keywords

3 fatty acids; Low birthweight; Minerals; Nutritional supplements; Preeclampsia

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETAMETHASONE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FISH OIL; FOLIC ACID; IRON; OMEGA 3 FATTY ACID; PLACEBO; PYRIDOXINE; SELENIUM; VITAMIN D; ZINC;

BIRTH WEIGHT; CLEFT LIP; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; FAST FOOD; FOOD COMPOSITION; HUMAN; INFANT NUTRITION; LIFESTYLE; MALNUTRITION; MATERNAL WELFARE; NUTRIENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REVIEW; SOCIETY; SPONTANEOUS ABORTION;

ANTIOXIDANTS; DEFICIENCY DISEASES; DEPRESSION, POSTPARTUM; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MINERALS; MOUTH ABNORMALITIES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33751019663     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e328010214e     Document Type: Review

References (61)

1. Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper and magnesium and risks for all-cause, cancer and cardiovascular mortality. Epidemiology 2006; 17:308-314.
2. Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001; 3:CD002124.
3. Guymer RH, Chong FW. Modifiable risk factors for age-related macular degeneration. Med J Aust 2006; 184:455-458.
4. Holness MJ, Greenwood GK, Smith ND, Sugden MC. Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology 2003; 144:3958-3968.
5. Mathias JR, Franklin R, Quast DC, et al. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril 1998; 70:81-88.
6. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the MRC Vitamin Study. Lancet 1991; 338:131-137.
7. Hoare J, Henderson L, Bates CJ, et al. The National Diet and Nutrition Survey: adults aged 19-64 years. Volume 5: summary report. London: HMSO; 2005.
8. Simopoulos AO. Omega 3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54:438-463.
9. Raijmakers MT, Peters WH, Steegers EA, Poston L. Amino thiols detoxification and oxidative stress in preeclampsia and other disorder of pregnancy. Curr Pharm Des 2005; 11:711-734.
10. Kim YH, Kim CH, Cho ML, et al. Total peroxyl radical-trapping ability and antioxidant vitamins of the umbilical venous plasma and the placenta in preeclampsia. J Obstet Gynaecol Res 2006; 32:32-41.
11. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial. Lancet 1999; 354:810-816.
12. Rumbold A, Duley L, Crowther C, Haslam R. Antioxidants for preventing preeclampsia. Cochrane Database Syst Rev 2005; 19:CD004227.
13. Rumbold AR, Crowther CA, Haslam RR, et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006; 354:1796-1806.
14. Poston L, Briley AL, Seed PT, et al. Vitamin Cand vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; 367:1145-1154. This large study is of special interest because it seems to contradict the earlier findings by the same research group.
15. Lindheimer MD, Sibai BM. Antioxidant supplementation in preeclampsia. Lancet 2006; 367:1119-1120.
16. Bodnar LM, Tang G, Ness RB, et al. Periconceptual multivitamin use reduces the risk of preeclampsia. Am J Epidemiol 2006; 164:470-477. This study highlights the use of a general all round multivitamin supplement which may have more of a synergistic effect, rather than individual nutrients.
17. Haim M, Tanne D, Goldbourt U, et al. Serum homocysteine and long term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology 2006; 107:52-56.
18. Maruotti G, Del Bianco A, Amato AN, et al. Preeclampsia and high serum levels of homocysteine. Minerva Ginecol 2005; 57:165-170.
19. Baksu A, Taskin M, Goker N, et al. Plasma homocysteine in late pregnancies complicated with preeclampsia and in newborns. Am J Perinatol 2006; 23:31-35. This study emphasises that further research needs to be designed to ask whether reducing homocysteine would be valuable in the prevention of preeclampsia.
20. Qiu C, Sanchez SE, Larrabure G, et al. Erythrocyte omega-3 and omega-6 polyunsaturated fatty acids and preeclampsia risk in Peruvian women. Arch Gynecol Obstet 2006; 274:97-103.
21. Langhoff-Roos J, Kesmodel, Jacobsson B, et al. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ 2006; 332:937-939.
22. Casanueva E, Ripoll C, Tolentino M, et al. Vitamin C supplementation to prevent premature rapture of the chorioaminiotic membranes: a randomised trial. Am J Clin Nutr 2005; 81:859-863. Vitamin C cannot be manufactured by the human body, so this study is interesting that it highlights the collage link to PROM and the possible consequences of a vitamin C deficiency.
23. Borna S, Borna H, Daneshbodie B. Vitamins C and E in the latency period in women with preterm premature rupture of membranes. Int J Gynaecol Obstet 2005; 90:16-20.
24. Olsen SF, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ 2002; 324:447.
25. Olsen SF, Soorensen JD, Secher NJ, et al. Fish oil supplementation and duration of pregnancy. A randomised controlled trial. Ugeskr Laeger 1994; 156:1302-1307.
26. Lamont RF, Sawant SR. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. Minerva Ginecol 2005; 57:423-433.
27. Nishijima K, Shukunami K, Kotsuji F. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labour. J Clin Gastroenterol 2005; 39:447-448.
28. Pizzo G, Giuliana G, Milici MF, Giangreco R. Effect of dietary carbohydrates on the in vitro epithelial adhesion of Candida albicans, Candida tropicalis and Candida krusei. New Microbiol 2000; 23:63-71.
29. Allen KG, Harris MA. The role of n-3 fatty acids in gestation and parturition. Exp Biol Med (Maywood) 2001; 226:498-506.
30. Osrin D, Vaidva A, Shrestha Y, et al. Effects of antenatal multiple micronutrient supplementation on birthweight and gestational duration in Nepal: double-blind randomised controlled trial. Lancet 2005; 365:955-962.
31. Morley R, Carlin JB, Pasco JA, Wark JD. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab 2006; 91:906-912.
32. Nowson CA, Magerison C. Vitamin D intake and vitamin D status of Australians. Med J Aust 2002; 177:149-152.
33. Schroth RJ, Lavelle CL, Moffatt ME. Review of vitamin D deficiency during pregnancy: who is affected? Int J Circumpolar Health 2005; 64:112-120.
34. Hypponen E. Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr Rev 2005; 63:225-232. With ongoing research in vitamin D and breast cancer, it is interesting to look at this vitamin's immunomodulatory effects and outcome of pregnancy.
35. Halhali A, Tovar AR, Torres N, et al. Preeclampsia is associated with low circulating levels of insulin-like growth factor 1 and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000; 85:1828-1833.
36. Scheplvagina LA. Impact of the mother's zinc deficiency on the woman's and newborn's health status. J Trace Elem Med Biol 2005; 19:29-35.
37. Favier M, Hininger-Favier I. Zinc and pregnancy. Gynecol Obstet Fertil 2005; 33:253-258.
38. Lindblad B, Zaman S, Malik A, et al. Folate, vitamin B12 and homocysteine levels in South Asian women with growth-retarded fetuses. Acta Obstet Gynaecol Scand 2005; 84:1055-1061.
39. Chen X, Scholl TO. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diab Rep 2005; 5:282-288.
40. Bo S, Lezo A, Menato G, et al. Gestational hyperglycemia, zinc, selenium and antioxidant vitamins. Nutrition 2005; 21:186-191.
41. Das UN. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 2005; 21:762-773. With the increase in obesity and Type II disease worldwide, it is important to know whether the conditions for the development of the metabolic syndrome are laid down in utero and, if so, how this could be prevented.
42. Tamura T, Munger RG, Corcoran C, et al. Plasma zinc concentrations of mothers and the risk of nonsyndrome oral clefts in their children: a case-control study in the Philippines. Birth Defects Res A Clin Mol Teratol 2005; 73:612-616. This study highlights an important issue as to whether congenital abnormalities, other than neural tube defects, could be prevented with the supplementation of nutrient, in this case zinc.
43. Hozvasz KK, Ruszczvnska A, Bulska F. Low zinc and high copper levels in mothers of children with isolated cleft lip and palate. Wiad Lek 2005; 58:382-385.
44. Nelson MM, Evans HM. Pteroylglutamic acid and reproduction in rats. J Nutr 1949; 38:11-14.
45. Laurence KN, James N, Miller MH, et al. Double blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ (Clin Res Ed) 1981; 282:1509-1511.
46. Daly S, Cotter A, Molloy AE, Scott J. Homocysteine and folic acid: implications for pregnancy. Semin Vasc Med 2005; 5:190-200.
47. Kumar KS, Kumar A, Prakash S, et al. Role of red cell selenium in recurrent pregnancy loss. J Obstet Gynecol 2002; 22:181-183.
48. Del Bianco A, Maruotti G, Fulgieri AM, et al. Recurrent spontaneous miscarriages and hyperhomocysteinemia. Minerva Ginecol 2004; 56:379-383.
49. Krabbendam I, Franx A, Bots ML, et al. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 2005; 118:143-153. This article is a critical review of the literature on pregnancy loss and as well as comments on the need to test for antiphospholipid antibodies, it also highlights the justification for testing for homocysteine which is often overlooked and modifiable with increased intake of B vitamins.
50. Rossi E, Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies: a pilot study. Lupus 1993; 2:319-323.
51. Carta G, Iovenitti P, Falciglia K. Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates. Clin Exp Obstet Gynecol 2005; 32:49-51. As aspirin is often use as a prophylactic, with or without the presence of antiphospholipid antibodies, in recurrent miscarriage, in-vitro fertilisation or even in women taking longer to conceive, this study shows the equivalent efficacy of fish oil to aspirin.
52. Rumbold A, Middleton P, Crowther CA. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev 2005; 18:CD004073.
53. Sontrop J, Campbell MK. Omega 3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 2006; 42:4-13.
54. Hibbein JR. Seafood consumption, the DHA content of mother's milk and prevalence rates of postpartum depression: a cross-national ecological analysis. J Affect Disord 2002; 69:15-29.
55. Freeman MP, Hibbein JR, Wisner KL, et al. Randomised dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006; 113:31-35. To have an alternative treatment for postpartum depression, especially in breastfeeding mothers, would be beneficial, especially if that nutrient conferred other benefits to mother and baby when used as a prophylactic in pregnancy.
56. Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very long chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003; 111:e39-e44.
57. Genuis SJ, Schwalfenberg GK. Time for an oil check: the role of essential omega 3 fatty acids in maternal and pediatric health. J Perinatol 2006; 26:359-365. This excellent review describes the function of essential fatty acids, the benefit to maternal health and pediatric health, and the public health considerations.
58. Dunstan JA, Prescott SL. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants. Curr Opin Allergy Clin Immunol 2005; 5:215-221.
59. Luke B. The evidence linking maternal nutrition and prematurity. J Perinat Med 2005; 33:500-505.
60. Bendich A, Leader S. Potential health economic benefits of vitamin supplementation. West J Med 1997; 166:306-312.
61. Leader S, Mallick R. Tapping the savings from vitamin-based prevention. Manag Care Interface 1998; 11:95-99.